Press Release

[DEER PARK, Ill. — June 9, 2026] — Leica Biosystems, a Danaher company and a global leader in end to end anatomic and digital pathology solutions, is advancing how pharmaceutical organizations scale digital and computational pathology to...

OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The collaboration encompasses Photocure's...

Collaboration will apply Aignostics AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9,...

MT Group: 23-year-old biospecimen CRO marks milestone with expanded capabilities for translational research, biomarker discovery, companion diagnostic development, and liquid biopsy validation across oncology and autoimmune programs LOS...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, Yale New Haven Hospital (YNHH) and Memorial Sloan Kettering Cancer Center (MSK) today announced the...

Proscia: National group positions itself as key partner for biopharmaceutical research, strengthening its role in precision medicine MELBOURNE, FL and PHILADELPHIA — June 3, 2026 — NextGen Pathology, a national group of general and...